August 14th 2023
The FDA has issued a complete response letter to the new drug application for avasopasem manganese to manage oral mucositis in patients with locally advanced head and neck cancer undergoing radiation.
2nd Annual International Congress on Pediatric Oncology
View More
Community Practice Connections™: 23rd Annual International Lung Cancer Congress®
View More
PER's Breast Cancer Symposia in San Antonio
Register Now!
2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition
Register Now!
BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer
View More
20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
9th Annual School of Gastrointestinal Oncology® (SOGO®)
Register Now!
New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
Register Now!
BURST CME™: What Is the Real Risk in Lower-Risk MDS?
View More
BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?
View More
BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS
View More
The Latest on Acute Lymphocytic Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
A Focus on Acute Myeloid Leukemia
View More
Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
23rd Annual International Congress on the Future of Breast Cancer® West
Register Now!
25th Annual International Lung Cancer Congress®
Register Now!
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!
View More
7th Annual School of Nursing Oncology™
View More
Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes
View More
Community Practice Connections™: 2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors
View More
Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens
View More
Shorter Radiotherapy Course Viable, Safe, and Cost-Saving in Low-Risk Prostate Cancer
October 17th 2016Deborah Watkins Bruner, RN, PhD, FAAN, discusses the results of a trial comparing quality of life after conventional radiotherapy and after a hypofractionated schedule for men at low-risk for prostate cancer.
Yoga Improves Quality of Life in Men Having Radiotherapy for Prostate Cancer
August 2nd 2016The health benefits of yoga are many, but in the oncology setting, studies of the approach have focused primarily on women with breast cancer. However, a small, first-of-its-kind study by researchers at the Perelman School of Medicine at the University of Pennsylvania is exploring how yoga may also improve treatment-related symptoms in men who are undergoing radiotherapy for their prostate cancer. And the results, thus far, are promising.
Abdominal Radiation May Increase Diabetes Risk in Childhood Cancer Survivors
January 20th 2016Previous studies have linked radiation to the pancreas during childhood to an increased risk of type 1 or 2 diabetes, and in a recent small study, researchers investigated the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
For Patients With Inoperable Stage I NSCLC, Race, Hospital, and Insurance Status Matter
December 2nd 2014Despite the proven benefits of SBRT for patients with inoperable stage I NSCLC, whether such patients are offered it depends on their race, insurance status, and the type of facility where they are being treated.
Fewer Side Effects, Cost Savings, With Single-Fraction Radiotherapy for Bone Metastases
August 6th 2014A new study has found that standardizing prescribing practices for single-fraction radiation therapy (SFRT) for palliation of bone metastases may result in cost savings and an improvement in patients' quality of life.